Simpler Grants.gov #HT942526ATRPCRA

Army Solicitation for Arthritis Clinical Research and Trials (FY26 ATRP)

The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is inviting applications for the FY26 Arthritis Research Program (ATRP) Clinical Research Award. - Purpose: Support clinical research and clinical trials focused on arthritis, emphasizing either Prevention/Early Diagnosis or Treatment/Mitigation of Disease Progression/Burden - Research Levels: - Level 1: Clinical research or early-phase/pilot clinical trials - Level 2: Full-scale clinical trials - Requirements: - Community collaborator required for Level 2, encouraged for Level 1 - Preliminary and/or published data required for all applications - Funding: - Total available: Approximately $7.15 million - Level 1: Up to $1.30 million per award (about three awards expected) - Level 2: Up to $3.25 million per award (one award expected) - Period of Performance: Up to four years for both levels - Eligibility: Open to extramural and intramural organizations, both foreign and domestic, for-profit and nonprofit, public or private entities - No specific OEMs, vendors, or products are identified, as this is a research grant opportunity, not a procurement of goods or commercial services

Description

The FY26 Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research evaluating disease-specific factors and interventions to generate clinically useful evidence for optimizing patient outcomes and informing clinical care or policy. Research addressing all types of arthritis is encouraged and must focus on either Prevention and Early Diagnosis or Treatment and Mitigation of Disease Progression/Burden. The award offers funding for two research levels: Level 1 for clinical research or early-phase/pilot clinical trials, and Level 2 for full-scale clinical trials. Applications should include a community collaborator and require preliminary or published data. The total funding amount is approximately $7.15 million to support about four awards with a maximum performance period of four years.

View original listing